Loading data for MDT — first visit, this takes a few seconds.
Medtronic (MDT)
NYSE: MDT
· Real-Time Price · USD
92.02
+0.88 (0.97%)
At close: Aug 26, 2026, 3:59 PM
The price, the headline numbers and the latest news, in one place.
Medtronic (MDT) Stock Price, Analysis & Data
0.97% (1D)
| Bid | 92.24 |
| Market Cap | 117.78B |
| Revenue (ttm) | 36.36B |
| Net Income (ttm) | 4.8B |
| 0.57 | |
| 3.76 | |
| 24.47 | |
| 14.37 | |
| P/B (ttm) | 2.38 |
| P/S (ttm) | 3.24 |
| Earnings Date | Sep 1, 2026 |
| Ask | 92.25 |
| Volume | 5,984,233 |
| Avg. Volume (20D) | 9,048,804 |
| Open | 91.08 |
| Previous Close | 91.14 |
| Day's Range | 90.75 - 92.53 |
| 52-Week Range | 73.31 - 106.33 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $2.88 (3.16%) |
| Ex-Dividend Date | Sep 25, 2026 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization th...
Industry Medical Devices
Sector Healthcare
IPO Date May 2, 1973
Employees 95,000
Stock Exchange NYSE
Ticker Symbol MDT
Website https://www.medtronic.com
Financial Performance
In 2026, Medtronic's revenue was 36.36B, an increase of 8.43% compared to the previous year's 33.54B. Earnings were 4.8B, an increase of 2.98%.
Financial StatementsEarnings Surprise
Medtronic has released their quarterly earnings on Jun 3, 2026:
- Revenue of $9.81B misses estimates by $0, with 9.86% YoY growth.
- EPS of 1.55 exceeds estimates by 0.01, with -4.32% YoY decline.
Medtronic is scheduled to release its earnings on Sep 1, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade




